Skip to main content

Macrogenics Inc

MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001125345

In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 13, 2026
$140.6M
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $129.1K in total
1
13F holdersQ2 2026, +13 vs. previous quarter
122
13F valueReported value at the end of Q2 2026
$224.9M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$149.5M
−0.3% year over year
Net income, FY2025
-$74.6M
No comparable prior period
Free cash flow, FY2025
-$83.0M
No comparable prior period
Revenue, Q3 FY2026
$18.7M
−74.4% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $74.6M (49.9% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.95M
Shares sold short
Change
−110.7K
−2.2% vs. previous
Days to cover
3.86
At average daily volume

Superinvestors holding MGNX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding MGNX at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Macrogenics Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 20, 2026 (view filing)6:19 PM ETAug 191 dayPeters Jeffrey StuartSenior VP, GC, and SecretarySSale−31.1K$4.15−$129.1K−100.0%0 after10b5-1
Aug 21, 2025 (view filing)Aug 19-202 daysHeiden William KDirectorPPurchase+100.0K$1.51+$150.5K+909.1%111.0K after2 lots
Feb 19, 2025 (view filing)Feb 154 daysSmith Beth AnnVP, Controller & TreasurerSSale−423$2.56−$1.08K−4.2%9.53K after
Apr 8, 2024 (view filing)Apr 44 daysPeters Jeffrey StuartSenior VP and General CounselSSale−51.4K$15.55−$799.1K−100.0%0 after5 lots10b5-1
Mar 8, 2024 (view filing)Mar 62 daysPeters Jeffrey StuartSenior VP and General CounselSSale−19.6K$21.50−$421.9K−68.8%8.89K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysRisser Eric BlasiusChief Operating OfficerSSale−41.2K$19.76−$813.5K−51.4%38.9K after2 lots10b5-1
Mar 6, 2024 (view filing)Mar 42 daysSpitznagel ThomasSr VP, Technical OpsSSale−10.0K$20.00−$200.0K−54.6%8.32K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysKarrels JamesSVP, CFO and SecretarySSale−30.0K$20.50−$615.0K−14.9%171.5K after10b5-1
Feb 28, 2024 (view filing)Feb 262 daysPeters Jeffrey StuartSenior VP and General CounselSSale−16.1K$17.22−$277.7K−64.4%8.89K after10b5-1
Feb 7, 2024 (view filing)Feb 7Same dayBonvini EzioSr VP, Research & CSOSSale−3.33K$18.00−$60.0K−4.5%71.3K after10b5-1

Top 10 13F holders, Q2 2026

See all 122 holders

The largest institutional positions in Macrogenics Inc at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding MGNX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC5,006,752$23.1M0.64%−1,005,248−16.7%Reduced
BlackRock, Inc.4,679,229$21.6M0.00%+3,516,083+302.3%Added
Vanguard Capital Management LLC2,656,010$12.3M0.00%+2,157+0.1%Added
Renaissance Technologies LLC2,632,750$12.2M0.02%−330,809−11.2%Reduced
Acadian Asset Management LLC2,542,643$11.7M0.01%−1,357−0.1%Reduced
Bank of America Corp2,488,252$11.5M0.00%+86,438+3.6%Added
Two Sigma Investments, LP2,465,699$11.4M0.01%−62,130−2.5%Reduced
Millennium Management LLC2,374,296$11.0M0.01%−420,061−15.0%Reduced
Wasatch Advisors Inc2,018,881$9.33M0.06%+459,180+29.4%Added
Ra Capital Management, L.P.1,864,176$8.61M0.07%00.0%Unchanged

Holders of 5% or more of MGNX

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Macrogenics Inc.

Largest holders of MGNX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G/A9.45%5.96M shares–Aug 14, 20251 filingAug 14, 2025SEC
Armistice Capital, LLC13G/A7.88%5.01M shares−1.58 ppfrom 9.46%Feb 14, 20238 filingsAug 14, 2026SEC
BlackRock, Inc.13G7.10%4.50M shares+4.20 ppfrom 2.90%Oct 22, 20244 filingsJul 29, 2026SEC